PQ in sterile manufacturing, aseptic filling and high risk operations

PQ in Sterile Manufacturing, Aseptic Filling, and High-Risk Operations Performance Qualification (PQ) in Sterile Manufacturing and Aseptic Filling Operations Performance Qualification (PQ) is an essential component of equipment qualification processes in the pharmaceutical industry, particularly in sterile manufacturing and aseptic filling environments. PQ under routine operating conditions ensures that equipment operates as intended and consistently produces products that meet quality specifications. This article serves as a comprehensive guide for pharma professionals navigating the critical aspects of PQ, focusing on regulatory frameworks such as FDA, EMA, and MHRA requirements. Understanding Performance Qualification in the Pharmaceutical Sector Performance Qualification (PQ) is a…

Continue Reading... PQ in sterile manufacturing, aseptic filling and high risk operations

How to link PQ outcomes to commercial batch release and ongoing CPV

How to Link PQ Outcomes to Commercial Batch Release and Ongoing CPV Linking PQ Outcomes to Commercial Batch Release and Ongoing CPV The link between Performance Qualification (PQ) outcomes and the processes of commercial batch release and ongoing Continuous Process Verification (CPV) is critical for ensuring product quality and regulatory compliance. In the competitive pharmaceutical landscape, understanding the integration of PQ within broader quality management systems is paramount for regulatory affairs professionals, clinical operations teams, and medical affairs personnel. This article delves into the essential strategies, regulatory expectations, and practical methodologies needed to establish robust linkages between PQ and CPV,…

Continue Reading... How to link PQ outcomes to commercial batch release and ongoing CPV

Integrating CQAs and CPPs into PQ sampling and monitoring strategies

Integrating CQAs and CPPs into PQ Sampling and Monitoring Strategies Integrating CQAs and CPPs into PQ Sampling and Monitoring Strategies Performance Qualification (PQ) under routine operating conditions is a critical component of the broader validation framework in pharmaceutical manufacturing and clinical research. The integration of Critical Quality Attributes (CQAs) and Critical Process Parameters (CPPs) into PQ sampling and monitoring strategies is instrumental in ensuring product quality, regulatory compliance, and operational excellence. This article explores the interaction between CQAs and CPPs in the context of Performance Qualification (PQ) and how these elements can be systematically incorporated into sampling and monitoring strategies….

Continue Reading... Integrating CQAs and CPPs into PQ sampling and monitoring strategies

Training teams on connecting PQ, PPQ and CPV in one lifecycle story

Training teams on connecting PQ, PPQ and CPV in one lifecycle story Training Teams on Connecting PQ, PPQ, and CPV in One Lifecycle Story The landscape of pharmaceutical manufacturing is undergoing rapid evolution, emphasizing the need for stringent regulatory compliance and robust quality assurance mechanisms. One of the critical aspects of maintaining compliance with the regulatory frameworks set forth by the FDA and other global authorities is understanding the lifecycle story of performance qualification (PQ), preparation performance qualification (PPQ), and continuous process verification (CPV). This article serves as a comprehensive guide for pharmaceutical professionals, including those in clinical operations, regulatory…

Continue Reading... Training teams on connecting PQ, PPQ and CPV in one lifecycle story

Global expectations FDA EMA MHRA for PQ vs PPQ terminology and scope

Global expectations FDA EMA MHRA for PQ vs PPQ terminology and scope Global Expectations FDA EMA MHRA for PQ vs PPQ Terminology and Scope In the pharmaceutical and biotechnology industries, understanding the nuances of regulatory expectations surrounding performance qualifications (PQ) and process performance qualifications (PPQ) is critical. Both terms play a pivotal role in ensuring equipment and systems meet required operational standards and are compliant with established regulations by entities such as the FDA, EMA, and MHRA. This comprehensive guide explores the definitions, scope, and expectations involved, presenting a clear framework for industry professionals engaged in regulatory affairs, quality assurance,…

Continue Reading... Global expectations FDA EMA MHRA for PQ vs PPQ terminology and scope

PQ considerations when scaling up, transferring or replicating lines

PQ Considerations When Scaling Up, Transferring or Replicating Lines PQ Considerations When Scaling Up, Transferring or Replicating Lines The landscape of pharmaceutical manufacturing is increasingly complex, driven by the need for flexibility, efficiency, and compliance with stringent regulatory requirements. Performance Qualification (PQ) is a critical phase in ensuring that equipment and processes operate as intended under routine conditions. Particularly when scaling up, transferring, or replicating production lines, understanding PQ requirements is essential for maintaining compliance with regulations set forth by entities such as the US FDA and the EMA in Europe. This article serves as a comprehensive manual detailing the…

Continue Reading... PQ considerations when scaling up, transferring or replicating lines

Digital tools for PQ data capture, review and lifecycle storage

Digital tools for PQ data capture, review and lifecycle storage Digital Tools for Performance Qualification (PQ) Data Capture, Review, and Lifecycle Storage Performance qualification (PQ) is a critical phase in the lifecycle of pharmaceutical equipment and systems that involves the assessment of equipment under routine operating conditions to ensure that it consistently performs according to predetermined specifications. The increasing reliance on digital tools for PQ data capture, review, and lifecycle storage has transformed how pharmaceutical companies approach compliance within the regulatory frameworks established by global authorities such as the FDA, EMA, and MHRA. This article presents a comprehensive overview of…

Continue Reading... Digital tools for PQ data capture, review and lifecycle storage

Internal audit focus areas for PQ robustness, traceability and evidence

Internal Audit Focus Areas for PQ Robustness, Traceability and Evidence Internal Audit Focus Areas for PQ Robustness, Traceability and Evidence In the pharmaceutical and biopharmaceutical industries, performance qualification (PQ) under routine operating conditions is a critical element of equipment qualification, outlined in regulatory frameworks such as the FDA’s 21 CFR Part 211, the EMA’s guidelines, and the MHRA’s expectations. Ensuring PQ robustness, traceability, and adequate evidence collection are paramount for compliance and operational excellence. This article presents an in-depth examination of the internal audit focus areas pertinent to PQ, particularly in relation to performance qualification (PQ) study design, sterile and…

Continue Reading... Internal audit focus areas for PQ robustness, traceability and evidence

Using statistics and trend tools to interpret PQ data meaningfully

Using Statistics and Trend Tools to Interpret PQ Data Meaningfully Using Statistics and Trend Tools to Interpret PQ Data Meaningfully Introduction to Performance Qualification (PQ) Under Routine Operating Conditions Performance Qualification (PQ) is a critical aspect of validation in pharmaceutical manufacturing, particularly during routine operations. PQ serves to ensure that a system operates consistently within its intended use, as specified in its design and performance verification stages. The regulatory guidelines, particularly those articulated by the FDA under 21 CFR Parts 210 and 211, mandate rigorous validation protocols that include PQ. In alignment with these regulations, data generated during PQ must…

Continue Reading... Using statistics and trend tools to interpret PQ data meaningfully

Structuring URS documents to cover capacity, quality, data and compliance

Structuring URS Documents to Cover Capacity, Quality, Data and Compliance Structuring User Requirement Specifications (URS) for Effective Compliance User Requirement Specifications (URS) are critical documents in the pharmaceutical industry used to define the essential criteria that equipment and systems must fulfill. A well-structured URS is pivotal in ensuring compliance with regulatory requirements outlined by the US FDA, EMA, and MHRA, especially when it comes to validation, data integrity, and risk management. This article presents a detailed guide on structuring URS documents to cover capacity, quality, data, and compliance effectively. In focusing on these elements, stakeholders can enhance overall operational efficiency…

Continue Reading... Structuring URS documents to cover capacity, quality, data and compliance